Eledon Pharma Q4 2023 GAAP EPS $(0.32) Beats $(0.39) Estimate

Eledon Pharmaceuticals Inc Ordinary Shares -7.45%

Eledon Pharmaceuticals Inc Ordinary Shares

ELDN

2.61

-7.45%

Eledon Pharma (NASDAQ: ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via